GUOQUAN (02517) intends to repurchase H shares based on the authorization to repurchase shares.

GUOQUAN (02517) Announced that the company's shareholders are expected to pass a resolution at the 2025 annual general meeting to grant the board of directors a general authorization to repurchase up to 10% of the company's issued H shares (excluding treasury shares) as of the date of approval of the general authorization resolution at the 2025 annual general meeting (repurchase authorization). The repurchase authorization will expire on the earlier of: the end of the 2026 annual general meeting of the company; or the date when the repurchase authorization is revoked or amended by special resolution of the shareholders' meeting. On April 22, 2026, the board of directors resolved, subject to the approval of the repurchase authorization by the shareholders' meeting, to implement a plan to repurchase H shares on the open market using no more than HK$200 million of the company's funds from the date of approval of the repurchase authorization by the shareholders' meeting until the expiration of the repurchase authorization (H share repurchase plan). The actual repurchase price per H share repurchased in each repurchase shall not exceed a premium of 5% or above the average closing price of H shares in the five trading days prior to each repurchase. H shares repurchased under the repurchase authorization may be cancelled or held as treasury shares. The board of directors believes that the current trading price of the shares does not fully reflect the company's intrinsic value and business prospects. Repurchasing shares at this stage will demonstrate the company's and management team's confidence in the company's business development prospects and growth potential, ultimately benefiting the company and creating value for shareholders.